ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Eur Respir J 2009; 34:1470-1476
Copyright ©ERS Journals Ltd 2009
doi: 10.1183/09031936.00122309

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Defres, S.
Right arrow Articles by Nathwani, D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Defres, S.
Right arrow Articles by Nathwani, D.

MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia

S. Defres1, C. Marwick2 and D. Nathwani1

1 Infection Unit, Ninewells Hospital and Medical School, and 2 MacKenzie Building, University of Dundee, Dundee, UK.

CORRESPONDENCE: D. Nathwani, Infection Unit, East Block, Level 4, Ninewells Hospital, DD1 9SY, Dundee, UK. E-mail: dilip.nathwani{at}nhs.net

Keywords: Community-acquired pneumonia, healthcare associated, hospital-acquired pneumonia, lung infections, methicillin-resistant Staphylococcus aureus, pulmonology

Received: July 31, 2009
Accepted August 27, 2009

Staphylococcus aureus has been recognised as a cause of community-acquired pneumonia, albeit uncommon, and an important cause of healthcare-associated (HA) pneumonia, including ventilator-associated pneumonia. Resistance of S. aureus to methicillin developed shortly after its introduction into clinical practice. Since then, methicillin-resistant S. aureus (MRSA) has predominantly been a feature of hospital-acquired, or latterly HA, infections as the boundaries became more blurred between the community and hospital environments.

However, more recently true community-acquired (CA)-MRSA infections have been detected and are becoming increasingly common, especially in the USA. Europe has not been immune to the development of MRSA in healthcare settings and although the prevalence of CA-MRSA is currently relatively low, there is the risk of wider spread. These new CA-MRSA strains appear to behave differently to HA-MRSA strains. Although predominantly causing skin and soft tissue infections, mainly as boils and abscesses requiring drainage, life threatening invasive infections including necrotising pneumonia can also occur. This article summarises the pathogenesis and clinical presentations of MRSA-related lung infections.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the European Respiratory Society.